| CANDRIAM EQUITIES L BIOTECHNOLOGY I CAP EUR | RVI BIOTECNOLOGÍA | 3.507,380000 | 02/07/2026 | 22,79% | 75,23% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I CAP USD | RVI BIOTECNOLOGÍA | 8.265,225020 | 02/07/2026 | 23,34% | 75,30% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I-H CAP EUR | RVI BIOTECNOLOGÍA | 3.282,880000 | 02/07/2026 | 18,18% | 71,87% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY N CAP USD | RVI BIOTECNOLOGÍA | 869,321870 | 02/07/2026 | 22,68% | 71,31% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R CAP EUR | RVI BIOTECNOLOGÍA | 521,390000 | 02/07/2026 | 22,91% | 77,86% | **** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R CAP USD | RVI BIOTECNOLOGÍA | 397,912098 | 02/07/2026 | 23,45% | 77,86% | **** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R-H CAP EUR | RVI BIOTECNOLOGÍA | 332,230000 | 02/07/2026 | 18,37% | 74,24% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY V CAP USD | RVI BIOTECNOLOGÍA | 3.028,300728 | 02/07/2026 | 23,42% | 75,89% | **** |
| CANDRIAM EQUITIES L EMERGING MARKETS C CAP EUR | RVI EMERGENTES | 1.562,200000 | 02/07/2026 | 28,71% | 83,95% | **** |
| CANDRIAM EQUITIES L EMERGING MARKETS C DIS EUR | RVI EMERGENTES | 948,310000 | 02/07/2026 | 26,33% | 71,72% | *** |
